GB1070492A - Sustained release tablets - Google Patents

Sustained release tablets

Info

Publication number
GB1070492A
GB1070492A GB3448/65A GB344865A GB1070492A GB 1070492 A GB1070492 A GB 1070492A GB 3448/65 A GB3448/65 A GB 3448/65A GB 344865 A GB344865 A GB 344865A GB 1070492 A GB1070492 A GB 1070492A
Authority
GB
United Kingdom
Prior art keywords
sustained release
aspirin
ether derivatives
cellulosic ether
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3448/65A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of GB1070492A publication Critical patent/GB1070492A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3448/65A 1964-01-27 1965-01-26 Sustained release tablets Expired GB1070492A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340496A US3388041A (en) 1964-01-27 1964-01-27 High dosage sustained release tablet

Publications (1)

Publication Number Publication Date
GB1070492A true GB1070492A (en) 1967-06-01

Family

ID=23333604

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3448/65A Expired GB1070492A (en) 1964-01-27 1965-01-26 Sustained release tablets

Country Status (9)

Country Link
US (1) US3388041A (US20080293856A1-20081127-C00150.png)
BE (1) BE658905A (US20080293856A1-20081127-C00150.png)
BR (1) BR6566484D0 (US20080293856A1-20081127-C00150.png)
DE (1) DE1492107C3 (US20080293856A1-20081127-C00150.png)
ES (1) ES308585A1 (US20080293856A1-20081127-C00150.png)
FI (1) FI51046C (US20080293856A1-20081127-C00150.png)
FR (1) FR4768M (US20080293856A1-20081127-C00150.png)
GB (1) GB1070492A (US20080293856A1-20081127-C00150.png)
SE (1) SE375236B (US20080293856A1-20081127-C00150.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467596A1 (fr) * 1979-10-25 1981-04-30 Fujisawa Pharmaceutical Co Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449489A (en) * 1965-10-21 1969-06-10 William E Gaunt Pharmaceutical compositions and their preparation
US3523141A (en) * 1967-04-26 1970-08-04 Nippon Zeon Co Method for inhibiting polymerization of conjugated dienes
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248856A (en) * 1979-07-10 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
JPS57500432A (US20080293856A1-20081127-C00150.png) * 1980-03-20 1982-03-11
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4673527A (en) * 1985-05-20 1987-06-16 Autotrol Corporation Tablet granulation
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
FR2723586A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Nouvelles compositions contenant de la cimetidine et associations en derivant
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
IN186245B (US20080293856A1-20081127-C00150.png) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
WO2007065559A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798443A (en) * 1954-07-21 1957-07-09 Smith Kline French Lab Multilayer tablet compressing machine
US2887440A (en) * 1957-08-12 1959-05-19 Dow Chemical Co Enteric coating
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
NL113512C (US20080293856A1-20081127-C00150.png) * 1962-01-25
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2467596A1 (fr) * 1979-10-25 1981-04-30 Fujisawa Pharmaceutical Co Compositions pharmaceutiques de tiaramide ou de son sel et d'un agent reglant la dissolution, a longue duree d'action
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics

Also Published As

Publication number Publication date
SE375236B (US20080293856A1-20081127-C00150.png) 1975-04-14
FI51046B (US20080293856A1-20081127-C00150.png) 1976-06-30
FR4768M (US20080293856A1-20081127-C00150.png) 1967-01-23
DE1492107C3 (de) 1973-12-06
DE1492107A1 (de) 1969-07-17
US3388041A (en) 1968-06-11
BE658905A (US20080293856A1-20081127-C00150.png) 1965-07-27
DE1492107B2 (de) 1973-04-26
FI51046C (fi) 1976-10-11
ES308585A1 (es) 1965-08-16
BR6566484D0 (pt) 1973-07-17

Similar Documents

Publication Publication Date Title
GB1070492A (en) Sustained release tablets
NL7604548A (nl) Werkwijze voor de bereiding van azapurinonen, alsmede werkwijze ter bereiding van farmaceuti- sche preparaten met anti-allergene werking, die deze verbindingen bevatten, alsmede de gevormde farmaceutische preparaten.
NL158388B (nl) Werkwijze voor de bereiding van farmaceutische tabletten of tabletkernen met verlengde werkingsduur en gevormde preparaten.
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
DK128053B (da) Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere.
FI49497C (fi) Menetelmä terapeuttisesti vaikuttavien 1-fenoksi-2-3-alkyyliaminopropa anien valmistamiseksi.
GB1204580A (en) Pharmaceutical dosage forms
NL140526B (nl) Werkwijze voor de bereiding van farmacologisch werkzame dibenzothiazepinen, werkwijze voor de bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL161434B (nl) Werkwijze voor de bereiding van farmaceutische prepara- ten met alfa-sympathicolytische werking, gevormde pre- paraten en werkwijze voor de bereiding van aminoalkyl- tetrahydro 1-ketonaftaleenderivaten.
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
NL143573B (nl) Werkwijze voor het bereiden van farmacologisch werkzame 1,4-tetrahydro-oxazinen, en van farmaceutische preparaten met een kalmerende en/of analgetische en/of anti-inflammatoire werking, die een of meer van deze verbindingen bevatten.
CA986947A (en) .alpha.-AMINOALKYL-4-HYDROXY-3-CARBOALKOXYAMINOBENZYL ALCOHOLS
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
NL156137B (nl) Werkwijze voor het bereiden van dibenzazepinederivaten met antidepressieve en analgetische werking, alsmede van farmaceutische preparaten, die deze verbindingen bevatten, en de gevormde preparaten.
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
IT942754B (it) Procedimento per la diffusione di impurita da una soluzione in un substrato
FI51900C (fi) Menetelmä tablettien valmistamiseksi, josta aktiivinen aine liukenee h idastetusti.
DK129287B (da) Fungicidt virksomme hydantoin-derivater.
FR1314M (fr) Tablette médicamenteuse a libération retardée.
GB1346610A (US20080293856A1-20081127-C00150.png)
NL159109B (nl) Werkwijze ter bereiding van cytostatisch werkzame derivaten van gefluoreerde pyrimidinenucleosiden, werkwijze ter bereiding van farmaceutische preparaten met cytostatische werking, alsmede de gevormde farmaceutische preparaten.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
FI49514C (fi) Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi.
USD214508S (en) Slidable-card locator map
NL175382C (nl) Werkwijze ter bereiding van antiflogistisch, analgetisch of antipyretisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van voor gebruik bij die werkwijze geschikte o-anilinofenylaceetamidederivaten.